Status:
UNKNOWN
The Effectiveness of Chlorhexidine Gluconate on Prevention of Catheter-Related Bloodstream Infections
Lead Sponsor:
Istanbul Medeniyet University
Conditions:
Central Venous Catheter Related Bloodstream Infection
Catheter-Related Infections
Eligibility:
All Genders
2-18 years
Phase:
NA
Brief Summary
Catheter-related bloodstream infections are associated with increased mortality, morbidity, and length of hospital stay. The incidence has decreased significantly with the strict implementation of pre...
Detailed Description
In patients with a central catheter for longer than 48 hours, the diagnosis of bloodstream infection will be recorded as laboratory-confirmed bloodstream infections according to CDC diagnostic criteri...
Eligibility Criteria
Inclusion
- Patients between the ages of 2 months and 18 years who had a temporary central venous catheter
- Patients whose follow-up is continued for at least 48 hours with a central venous catheter
Exclusion
- Patients younger than 2 months of age
- Patients with a intensive care unit stay shorter than 48 hours
- Immunosuppressive patients
- Patients with a history of allergic reaction to chlorhexidine
- Patients with skin lesions that interfere with skin cleansing with chlorhexidine
- Patients whose family did not give consent
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05995080
Start Date
May 1 2022
End Date
May 1 2024
Last Update
August 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IMU
Istanbul, Kadıköy, Turkey (Türkiye), 34800